Stada Recruits Ex-Sandoz Exec To Help Steer Biosimilars
Christine Berndt Previously Headed Biosimilar Development Programs At Sandoz
Executive Summary
Stada has announced the appointment of former Sandoz executive Christine Berndt as head of global development for specialty and biosimilar products, replacing Michael Mack.